ADM, a global leader in innovative solutions from nature, has announced findings from a recent clinical study on the effects of PRIOME®MH, a postbiotic derived from Bifidobacterium animalis subsp. lactis CECT 8145, in adult dogs. The study revealed that the postbiotic supports healthy blood sugar levels, with a significant reduction in postprandial blood glucose levels observed after a normal kibble meal compared to a placebo, particularly during a weight loss phase. Additionally, lower levels of gamma-glutamyl transferase, a liver function marker, were noted during a weight gain phase. The results suggest a potential role for PRIOME®MH in supporting canine metabolic health, contributing to the growing interest in functional pet nutrition.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。